These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 25615282)
1. Local delivery of paclitaxel in the treatment of peripheral arterial disease. Ng VG; Mena C; Pietras C; Lansky AJ Eur J Clin Invest; 2015 Mar; 45(3):333-45. PubMed ID: 25615282 [TBL] [Abstract][Full Text] [Related]
2. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial. Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel Drug-Eluting Stents in Peripheral Arterial Disease: A Health Technology Assessment. Health Quality Ontario Ont Health Technol Assess Ser; 2015; 15(20):1-62. PubMed ID: 26719778 [TBL] [Abstract][Full Text] [Related]
4. Drug-coated balloons and their place in treating peripheral arterial disease. Schnorr B; Albrecht T Expert Rev Med Devices; 2013 Jan; 10(1):105-14. PubMed ID: 23278227 [TBL] [Abstract][Full Text] [Related]
6. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents? Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201 [TBL] [Abstract][Full Text] [Related]
7. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Liistro F; Porto I; Angioli P; Grotti S; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L Circulation; 2013 Aug; 128(6):615-21. PubMed ID: 23797811 [TBL] [Abstract][Full Text] [Related]
8. Drug eluting devices for critically ill patients: can we apply lessons learned from the treatment of peripheral artery disease? Werner M; Scheinert D Adv Drug Deliv Rev; 2014 Nov; 77():32-9. PubMed ID: 25049084 [TBL] [Abstract][Full Text] [Related]
9. Paclitaxel-eluting stents for the treatment of femoropopliteal arterial stenoses: focus on the Zilver PTX drug-eluting peripheral stent. Moukarbel GV; Burket MW Expert Rev Med Devices; 2015 Mar; 12(2):157-62. PubMed ID: 25418344 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic Study of Paclitaxel Concentration after Drug-Eluting Balloon Angioplasty in the Iliac Artery of Healthy and Atherosclerotic Rabbit Models. Fernández-Parra R; Laborda A; Lahuerta C; Lostalé F; Aramayona J; de Blas I; de Gregorio MA J Vasc Interv Radiol; 2015 Sep; 26(9):1380-7.e1. PubMed ID: 26190185 [TBL] [Abstract][Full Text] [Related]
11. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials. Cassese S; Byrne RA; Ott I; Ndrepepa G; Nerad M; Kastrati A; Fusaro M Circ Cardiovasc Interv; 2012 Aug; 5(4):582-9. PubMed ID: 22851526 [TBL] [Abstract][Full Text] [Related]
12. Local drug delivery for treatment of coronary and peripheral artery disease. Gertz ZM; Wilensky RL Cardiovasc Ther; 2011 Dec; 29(6):e54-66. PubMed ID: 20553281 [TBL] [Abstract][Full Text] [Related]